SMTL ID : 5dls.1

Identification of Novel, in vivo Active Chk1 Inhibitors Utilizing Structure Guided Drug Design

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

monomer

Ligands

1 x 5CV: 1-benzyl-N-(5-{5-[3-(dimethylamino)-2,2-dimethylpropoxy]-1H-indol-2-yl}-6-oxo-1,6-dihydropyridin-3-yl)-1H-pyrazole-4-carboxamide(Non-covalent)

5CV.1: 19 residues within 4Å: Chain A: T.14, L.15, G.18, A.19, G.21, E.22, V.23, A.36, K.38, E.55, L.84, E.85, Y.86, C.87, S.88, G.90, L.137, S.147, D.148 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.15, A:V.23, A:L.137 Hydrogen bonds: A:E.85, A:C.87, A:C.87 Water bridges: A:E.91, A:S.147, A:S.147, A:D.148 Salt bridges: A:D.94 pi-Cation interactions: A:K.38

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: F.93, Y.173, G.204, E.205 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.173, A:Y.173

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Massey, A.J. et al., Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design. Oncotarget (2015)

Release Date

2015-10-14

Peptides

Serine/threonine-protein kinase Chk1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase Chk1

Related Entries With Identical Sequence